10/15/2026
How do we keep moving veterinary diagnostics forward? It starts with asking questions.
Today, we’re excited to share new peer-reviewed research published in the Journal of the American Veterinary Medical Association - JAVMA. In this study, Accuplex™ demonstrated 94% sensitivity for detecting antibodies to Ehrlichia spp. in dogs, compared with 58% for IDEXX SNAP® 4Dx® Plus, using indirect fluorescent antibody testing (IFA) as the reference method. Both tests showed high, comparable sensitivity for Anaplasma spp.
Better Petcare means asking how we can stay ahead of evolving diseases and do better for the pets in our care.
Routine vector-borne disease screening matters more than ever. See what Accuplex™ can do for you, your patients, and your practice.
Explore the findings: https://hubs.li/Q04BlH640
🐾 If you’ve made it this far, we’d love to hear: As tick-borne diseases continue to evolve, what advances would make the biggest difference in your practice?